Search research articles
Contact Us
Filters
Showing results (221-230 of 232) with videos related to
Page
of 24
Sort By:
Skeletal Radiology
|
June 10, 2023
Society of skeletal radiology position paper - recommendations for contrast use in musculoskeletal MRI: when is non-contrast imaging enough?
Jonathan D Samet, Hamza Alizai, Majid Chalian, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|
January 16, 2008
The Cairo kidney center protocol for rapamycin-based sequential immunosuppression in kidney transplant recipients: 2-year outcomes
Rashad S Barsoum, Ahmed A Morsey, Irene R Iskander, et al.
Orthopaedic Journal of Sports Medicine
|
November 23, 2020
Association Between MRI-Based Tibial Slope Measurements and Mucoid Degeneration of the Anterior Cruciate Ligament: A Propensity Score-Matched Case-Control Study
Bashir Zikria, Alex Johnson, Nima Hafezi-Nejad, et al.
Plos One
|
March 21, 2014
An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting
Nawaz Hack, Sarah M Fayad, Erin H Monari, et al.
European Radiology
|
January 21, 2015
Assessment of image quality in soft tissue and bone visualization tasks for a dedicated extremity cone-beam CT system
S Demehri, A Muhit, W Zbijewski, et al.
Neurology
|
July 7, 2021
Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment
Shivani Ahlawat, K Ina Ly, Laura M Fayad, et al.
British Journal of Cancer
|
October 14, 2015
Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI
J Guo, J O Glass, M B McCarville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2026
Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Neurology
|
August 17, 2016
Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis
Shivani Ahlawat, Laura M Fayad, Muhammad Shayan Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 232) with videos related to
Sort By:
Page
of 24
Skeletal Radiology
|
June 10, 2023
Society of skeletal radiology position paper - recommendations for contrast use in musculoskeletal MRI: when is non-contrast imaging enough?
Jonathan D Samet, Hamza Alizai, Majid Chalian, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|
January 16, 2008
The Cairo kidney center protocol for rapamycin-based sequential immunosuppression in kidney transplant recipients: 2-year outcomes
Rashad S Barsoum, Ahmed A Morsey, Irene R Iskander, et al.
Orthopaedic Journal of Sports Medicine
|
November 23, 2020
Association Between MRI-Based Tibial Slope Measurements and Mucoid Degeneration of the Anterior Cruciate Ligament: A Propensity Score-Matched Case-Control Study
Bashir Zikria, Alex Johnson, Nima Hafezi-Nejad, et al.
Plos One
|
March 21, 2014
An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting
Nawaz Hack, Sarah M Fayad, Erin H Monari, et al.
European Radiology
|
January 21, 2015
Assessment of image quality in soft tissue and bone visualization tasks for a dedicated extremity cone-beam CT system
S Demehri, A Muhit, W Zbijewski, et al.
Neurology
|
July 7, 2021
Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment
Shivani Ahlawat, K Ina Ly, Laura M Fayad, et al.
British Journal of Cancer
|
October 14, 2015
Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI
J Guo, J O Glass, M B McCarville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2026
Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Neurology
|
August 17, 2016
Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis
Shivani Ahlawat, Laura M Fayad, Muhammad Shayan Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2016
Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas
Jaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Page
of 24